Next-Generation Strategies to Encounter Antimicrobial Resistance (AMR): From Lariocidin to Gene Editing and Nanotechnology-Based Approaches
Molecules · 07.07.2026 · 31 (13) · 2395
DOI: 10.3390/molecules31132395 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 07.07.2026. Verfasst von Ilknur Yilmaz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, İstanbul Atlas University, Istanbul 34408, Turkey. Hauptthemen laut MEDLINE: Gene Editing, Antimicrobial Peptides, Nanotechnology, Drug Resistance, Bacterial. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The escalation of antimicrobial resistance (AMR) represents a serious global threat to public health, with AMR-associated mortality estimated to increase by 70% by 2050. As pathogens evolve through enzymatic inactivation, target modification, efflux-mediated clearance, biofilm formation, and broader genetic adaptation, conventional therapies are increasingly compromised, while the antibiotic development pipeline remains critically constrained by high discovery and development costs, weak commercial incentives, and the escalating complexity of resistance mechanisms. This review comprehensively synthesizes advanced pharmacological and biotechnological innovations designed to circumvent these entrenched resistance mechanisms. We highlight the development of novel therapeutic classes, particularly lariocidin, which disrupts bacterial protein synthesis via a previously unexploited ribosomal-binding site. Moreover, we critically evaluate molecular interventions, emphasizing CRISPR/Cas-based gene silencing and genome editing as precise tools to neutralize specific resistance determinants, such as the mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). Concurrently, we explore the integration of engineered nanoparticles to revitalize existing antimicrobials by overcoming biofilm barriers, improving drug solubility, and enabling targeted delivery. Collectively, mastering the evolving AMR landscape requires a multidimensional framework that seamlessly integrates these novel molecular targets with advanced rapid diagnostics and robust international governance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, İstanbul Atlas University, Istanbul 34408, Turkey.
- Department of Molecular Biology and Genetics, Graduate School of Science & Engineering, Yildiz Technical University, Istanbul 34220, Turkey.
- Department of Physics and Astronomy, University of Nigeria, Nsukka 410001, Nigeria.
- Department of Bioengineering, Yildiz Technical University, Istanbul 34220, Turkey.
- Graduate School of Science and Technology, Niigata University, Nishi-ku, Niigata 950-2181, Japan.
ORCID-Profile: Ilknur Yilmaz, Bekir Mustafa Yoğurtçu, Samson Aisida, Enes Baki Ezer
Zitieren
APA
Yilmaz, I., Yoğurtçu, B. M., Aisida, S., & Ezer, E. B. (2026). Next-Generation Strategies to Encounter Antimicrobial Resistance (AMR): From Lariocidin to Gene Editing and Nanotechnology-Based Approaches. Molecules, 31(13), 2395. https://doi.org/10.3390/molecules31132395
Vancouver
Yilmaz I, Yoğurtçu BM, Aisida S, Ezer EB. Next-Generation Strategies to Encounter Antimicrobial Resistance (AMR): From Lariocidin to Gene Editing and Nanotechnology-Based Approaches. Molecules. 2026;31(13):2395. doi:10.3390/molecules31132395
BibTeX
@article{Yilmaz2026,
author = {Yilmaz, Ilknur and Yoğurtçu, Bekir Mustafa and Aisida, Samson and Ezer, Enes Baki},
title = {Next-Generation Strategies to Encounter Antimicrobial Resistance (AMR): From Lariocidin to Gene Editing and Nanotechnology-Based Approaches},
journal = {Molecules},
year = {2026},
volume = {31},
number = {13},
pages = {2395},
doi = {10.3390/molecules31132395}
}
EUVIMED